Welcome to the healthcare professionals section
In this section you will find information on the product TendoVis™ and its use in the treatment of grade I and II ankle sprains. We have included TendoVis™ prescribing information, clinical references, a video demonstrating the “fanning” injection technique and other useful information.
If you require further assistance, please contact us.
A clinical study against placebo have shown that TendoVis™ gave the majority of patients to attain pain-free and disability-free return to sports (and daily activities) 6 days faster in a 17 days recovery period.
If you want to have more information, please click here.
By obtaining the full potential of interactions within the fibrin network of the injured ligaments, a better quality of healing is possible as TendoVis™ is most likely able to strengthen the ankle’s ligaments during the healing process and reduce scar tissue formation.
TendoVis™ containing STABHA™ can aid the healing process to complete with less scar tissue formation thus providing an excellent quality of healing. This allows the ankle to regain its former strength thus, reducing the rate of recurrence.
Hyaluronic acid has an ancillary effect of reducing pain and limit inflammation. TendoVis™ containing STABHA™ will help reduce the pain and limit inflammation in an ankle sprain due to these ancillary effects with low probability of systemic side effects (none experienced during clinical trials until now).
TendoVis™ is a peri-articular injection that can only be performed by a medical professional that has been trained in the injection technique. TendoVis™ should be injected into the injury site within 48 hours of the injury and the 2nd injection to be administered 48 hours after the 1st injection.
TendoVis™ was designed to be used concurrently with the R.I.C.E. (rest, ice compression and elevation) principle. Using TendoVis™ together with R.I.C.E. will allow the patient to regain range of motion quicker.
TendoVis™ containing STABHA™ (Soft Tissue Adapted Biocompatible Hyaluronic Acid) has been designed specifically to interact optimally with soft tissue ligaments and tendons due to its purity profile and biocompatibility.
When STABHA™ is injected into the site of injury, it reacts rapidly and efficiently with the torn ligaments. Hyaluronic acid acts as a dynamic supporting feature as it binds to the torn ligamentous fibres, strengthening the fibrin network of the ligaments.
By saturating the injury site with STABHA™, the full potential of its supportive role is achieved.
The main content of TendoVis™ is STABHA™ (Soft Tissue Adapted Biocompatible Hyaluronic Acid).
TendoVis™ is a registered product with the CE mark and both TendoVis™ and the manufacturing process for STABHA™ are patented.
TendoVis™ is used for treating Grade 1 and 2 ankle sprains. It is administered via a peri-articular injection into the site of injury using the fanning technique. The fanning technique helps to spread TendoVis™ over a large surface area within the injury site to have optimal interactions with the torn ligaments.